← Back
$AKTX All transactions

Akari Therapeutics Plc

▲ BUY
8 / 10

Conviction

$ Value

$10K

Shares

24,745

Price

$0

Filed

Dec 18

Why this score? (8/10)
  • Open market buy (+3)
  • C-suite insider (+2)
  • Cluster: 8 insiders buying (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

Farag Kameel D.

Title

Interim CFO

CIK

0002093620

Roles

Officer

Transaction Details

Transaction Date

2025-12-16

Code

P

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

24,745

Footnotes

Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer. | On December 16, 2025, the Reporting Person acquired (i) unregistered pre-funded warrants to purchase up to 24,745 ADSs (the "PIPE PFWs" and ) and (ii) accompanying Series G Warrants to purchase up to 24,745 ADSs (the "Series G Warrants"), at a combined purchase price of $0.4041 per PIPE PFW and Series G Warrant in a private placement transaction pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended. | The Series G Warrants and the PIPE PFWs shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the Private Placement Unregistered Warrants remaining exercisable until fully exercised. | The combined purchase price per one PIPE PFW and accompanying PIPE Series G Warrant was $0.4041. | Conversion Exercise Price of Security is $0.00001

Filing Info

Accession No.

0001493152-25-028419

Form Type

4

Issuer CIK

0001541157

Farag Kameel D.'s History

Date Ticker Type Value
2026-01-05 BIVI A $0
2025-12-16 AKTX
2025-12-16 AKTX $10K
2025-11-01 AKTX A $24K
2025-11-01 AKTX A $20K
2025-10-22 AKTX A $5K

Other Insiders at AKTX (90d)

Insider Bought Sold Last
Neal James R $2K 2025-12-16